[go: up one dir, main page]

HN2008000582A - Composiciones de suplementos de hierro de tolerancia mejorada - Google Patents

Composiciones de suplementos de hierro de tolerancia mejorada

Info

Publication number
HN2008000582A
HN2008000582A HN2008000582A HN2008000582A HN2008000582A HN 2008000582 A HN2008000582 A HN 2008000582A HN 2008000582 A HN2008000582 A HN 2008000582A HN 2008000582 A HN2008000582 A HN 2008000582A HN 2008000582 A HN2008000582 A HN 2008000582A
Authority
HN
Honduras
Prior art keywords
compositions
improved tolerance
iron supplements
effective amount
tolerance iron
Prior art date
Application number
HN2008000582A
Other languages
English (en)
Inventor
Krebs Meter
Krebs-Bensch Allison
Mincy Jerome
Original Assignee
Grace Procurements Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37902204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN2008000582(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grace Procurements Llc filed Critical Grace Procurements Llc
Publication of HN2008000582A publication Critical patent/HN2008000582A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A COMPOSICIONES Y MTODOS PARA EL TRATAMIENTO O LA PROFILAXIS DE LA DEFINICION DE LA DEFICIENCIA DE HIERRO Y PARTICULARMENTE DE LA ANEMIA DE DEFICIENCIA DE HIERRO, ADMINISTRANDO UNA COMPOSICION QUE CONTIENE UNA CANTIDAD EFECTIVA DE UNA SAL FERROSA DE HIERRO FARMACEUTICAMENTE ACEPTABLE Y UNA CANTIDAD EFECTIVA DEL COMPLEJO DE HIERRO DE POLISACARIDO
HN2008000582A 2005-10-04 2008-04-03 Composiciones de suplementos de hierro de tolerancia mejorada HN2008000582A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/243,043 US20070077313A1 (en) 2005-10-04 2005-10-04 Toleration iron supplement compositions

Publications (1)

Publication Number Publication Date
HN2008000582A true HN2008000582A (es) 2011-11-09

Family

ID=37902204

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2008000582A HN2008000582A (es) 2005-10-04 2008-04-03 Composiciones de suplementos de hierro de tolerancia mejorada

Country Status (10)

Country Link
US (2) US20070077313A1 (es)
EP (1) EP1945032A4 (es)
CA (1) CA2624619C (es)
CR (1) CR9857A (es)
CU (1) CU23776B7 (es)
EC (1) ECSP088348A (es)
HN (1) HN2008000582A (es)
SV (1) SV2009002862A (es)
TW (1) TWI358299B (es)
WO (1) WO2007044180A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
ES2426445T3 (es) * 2006-04-07 2013-10-23 Merrion Research Iii Limited Forma de dosificación oral sólida que contiene un potenciador
KR20110007614A (ko) * 2008-05-07 2011-01-24 메리온 리서치 Ⅲ 리미티드 ＧｎＲＨ 관련 화합물의 조성물 및 제조 방법
JP2012518686A (ja) * 2009-02-25 2012-08-16 メリオン・リサーチ・Ｉｉｉ・リミテッド ビスホスホネート類の組成物および薬物送達
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
WO2011120033A1 (en) * 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
AU2012204213A1 (en) * 2011-01-07 2013-06-13 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
CN102167752B (zh) * 2011-05-23 2012-08-08 华南理工大学 一种水溶性大豆多糖亚铁配合物的制备方法
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
ES2975708T3 (es) 2015-01-29 2024-07-12 Novo Nordisk As Comprimidos que comprenden agonista del GLP-1 y recubrimiento entérico
WO2022198329A1 (en) * 2021-03-26 2022-09-29 Alberta Veterinary Laboratories Ltd. Water-based iron supplement formulations for dosing animal neonates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821192A (en) * 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
IT1251702B (it) * 1991-10-16 1995-05-19 Mediolanum Farmaceutici Srl Complessi del ferro con la conalbumina e i suoi derivati
WO2000061191A2 (en) * 1999-04-09 2000-10-19 Advanced Magnetics, Inc. Heat stable coated colloidal iron oxides
US20030190355A1 (en) * 2002-04-05 2003-10-09 Hermelin Marc S. Modified release minerals
US7994217B2 (en) * 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
ES2358151T3 (es) * 2002-08-15 2011-05-06 Euro-Celtique S.A. Composiciones farmacéuticas que comprenden un antagonista opioide.
US7569560B2 (en) * 2004-03-19 2009-08-04 Warner Chilcott Company Llc Extended cycle multiphasic oral contraceptive method
US7585527B2 (en) * 2005-09-19 2009-09-08 Bala Venkataraman Composition and method for treating iron deficiency anemia

Also Published As

Publication number Publication date
ECSP088348A (es) 2008-07-30
CA2624619A1 (en) 2007-04-19
EP1945032A2 (en) 2008-07-23
EP1945032A4 (en) 2009-04-15
CU23776B7 (es) 2012-02-15
SV2009002862A (es) 2009-01-27
CA2624619C (en) 2018-03-13
WO2007044180A2 (en) 2007-04-19
CR9857A (es) 2008-07-29
US20110052722A1 (en) 2011-03-03
TWI358299B (en) 2012-02-21
US20070077313A1 (en) 2007-04-05
WO2007044180A3 (en) 2007-07-12
CU20080054A7 (es) 2010-08-30

Similar Documents

Publication Publication Date Title
HN2008000582A (es) Composiciones de suplementos de hierro de tolerancia mejorada
GT200900027A (es) Compuestos organicos
CL2008003016A1 (es) Composicion para tratamiento de lavanderia que comprende una base de tratamiento de lavanderia y desde 0,01 a 10% en peso de particulas de film laminar concavas coloreadas.
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
CL2011000933A1 (es) El compuesto 2-[(5-cloro-2-{[3-metil-1-(1-metiletil)-1h-pirazol-5-il]amino}-4-piridinil)amino]-n-(metiloxi)benzamida y sus sales, inhibidor de la quinasa de adhesion focal (fak); composicion farmaceutica que lo comprende; y su uso para el tratamiento del cancer.
PA8846901A1 (es) Inhibidores de cinasa akt y p70 s6.
SV2009002866A (es) Mezcla de sales de hierro y cobre que enmascaran el sabor metalico
HN2012001162A (es) Triazolopiridinas
BR112014017749A8 (pt) Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo
CR10479A (es) Modulares bencimidazolicos de vr1
GT200800276A (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
GT201200038A (es) Composicion para tratar la fibrosis quistica
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
BR112015028674A2 (pt) composição detergente compacta fluida para lavagem de roupas
UY30778A1 (es) Compuestos de 5,6-dihidro-1h-piridin-2-ona
MX2009013536A (es) Una nueva composicion coadyuvante a base de aceite.
CL2012002815A1 (es) Composicion para el cuidado bucal que comprende uno o mas compuesto de curcumina y una fuente de iones de zinc; correspondiente a 0.02 a 3% en peso de citrato de zinc; y uso de una fuente de iones de zinc para suprimir la degradacion y/o decoloracion del compuesto de curcumina en una composicion ara el cuidado bucal.
MX2018007865A (es) Composiciones para el cuidado personal.
MX354483B (es) Composición antimicrobiana.
BRPI0909211B8 (pt) formulação oral em forma de comprimido de compostos de tetraciclina
EA201400666A1 (ru) Противомикробная композиция
BR112015023878A2 (pt) composto, composição farmacêutica, e, uso de um composto
HN2008001531A (es) Composicion farmaceutica que comprenden la combinacion de una sal de ketorolaco y vitamina del complejo b para el tratamiento de la neuralgia
ECSP13012904A (es) Compuestos de complejos de fe(iii) para el tratamiento y profilaxis de síntomas de deficiencia de hierro y anemias por deficiencia de hierro